Other
Stem Cell Therapeutic and Research Reauthorization Act of 2025
This bill authorizes approximately $33 million per year from fiscal years 2027 through 2031 for national programs that connect patients with bone marrow and umbilical cord blood donors. It replaces a rigid target of collecting 150,000 cord blood units with a flexible mandate to maintain a high-quality, genetically diverse supply based on current medical science. Additionally, it allows federal health officials to transfer cord blood units to new storage facilities if a bank shuts down or fails quality standards, ensuring usable samples remain available to patients.
People affected—The number of stem cell transplant patients, donors, and cord blood banks affected is not specified in the bill text.
Fiscal magnitude$165.0Mprovisional · pending reviewSec. 2 authorizes $33,009,000 for each of fiscal years 2027 through 2031 ($165,045,000 total) for the C.W. Bill Young Cell Transplantation Program. Sec. 3(f) reauthorizes National Cord Blood Inventory funding without stating a specific dollar amount in the provided text.
Reach28provisional · pending reviewrigor: heuristic llm
What this bill touches.
Spending vs. restraint+28Public R&D+30
Who it helps · who it burdens.
Who it helps
- qualified cord blood banks and cell transplantation programsSec. 2 and Sec. 3(f) authorize $33,009,000 annually from FY 2027 through 2031 for the C.W. Bill Young Cell Transplantation Program and reauthorize funding for the National Cord Blood Inventory program; qualified banks can also receive transferred inventory from closing facilities (Sec. 3(b)).
- patients needing cell or cord blood transplantsSec. 3(a) and Sec. 3(d) direct HHS to actively manage the National Cord Blood Inventory to ensure genetic diversity, clinical utility, and a sufficient supply of high-quality cord blood units meeting FDA standards for transplant.
Who it burdens
- non-compliant or closing cord blood banksSec. 3(b) authorizes HHS to seize and transfer collected cord blood units to other qualified entities if a bank closes or fails to meet federal and industry operating and quality standards.
- Department of Health and Human ServicesSec. 3(a)–(d) mandates that the Secretary assess supply levels, evaluate scientific evidence for contracting, manage inventory composition and disposal, and oversee the transfer of units from non-operational banks.
Who backs it
- federal taxpayersSec. 2 and Sec. 3(f) authorize federal appropriations of $33,009,000 annually for FY 2027 through 2031 to fund the cell transplantation program and National Cord Blood Inventory.